Davita Inc's Suppliers recorded an increase in sales by 6.26 % year on year in Q2 2026, sequentially sales grew by 5.37 %, while their net profit margin fell to 5.85 % year on year, compared to the previous quarter Davita Inc's Suppliers had a lower net margin at 5.37 %,
Davita Inc's Suppliers recorded an increase in sales by 6.26 % year on year in Q2 2026, sequentially sales grew by 5.37 %, while their net profit margin fell to 5.85 % year on year, compare to previous quarter DVA's Suppliers had lower net margin at 5.85 %,
FMC also manufactures a full line of dialysis supplies and equipment in addition
to owning and operating outpatient dialysis centers worldwide. This may give FMC
cost advantages over us because of their ability to manufacture their own products.
However, FMC has been one of our largest suppliers of dialysis products and equipment
over the last several years. In January 2010, we entered into an agreement with
FMC which committed us to purchase a certain amount of dialysis equipment, parts
and supplies from FMC through 2013. In addition, in August 2006 in connection
with the DVA Renal Healthcare acquisition, we also entered into a product supply
agreement with Gambro Renal Products, Inc. (Gambro) that requires us to purchase
a certain amount of our hemodialysis non-equipment product supplies, such as dialyzers,
at fixed prices through 2015. Our purchases of products in these categories generally
offered by both FMC and Gambro represent approximately 4% of our total U.S. dialysis
operating expenses. During 2013, we purchased hemodialysis products and supplies
from Gambro representing approximately 2% of our total U.S. dialysis operating
expenses.
Davita Inc's Comment on Supply Chain
FMC also manufactures a full line of dialysis supplies and equipment in addition
to owning and operating outpatient dialysis centers worldwide. This may give FMC
cost advantages over us because of their ability to manufacture their own products.
However, FMC has been one of our largest suppliers of dialysis products and equipment
over the last several years. In January 2010, we entered into an agreement with
FMC which committed us to purchase a certain amount of dialysis equipment, parts
and supplies from FMC through 2013. In addition, in August 2006 in connection
with the DVA Renal Healthcare acquisition, we also entered into a product supply
agreement with Gambro Renal Products, Inc. (Gambro) that requires us to purchase
a certain amount of our hemodialysis non-equipment product supplies, such as dialyzers,
at fixed prices through 2015. Our purchases of products in these categories generally
offered by both FMC and Gambro represent approximately 4% of our total U.S. dialysis
operating expenses. During 2013, we purchased hemodialysis products and supplies
from Gambro representing approximately 2% of our total U.S. dialysis operating
expenses.
DVA's Suppliers Net profit fell by
DVA's Suppliers Net margin fell in Q2 to
-11.21 %
5.85 %
DVA's Suppliers Net profit fell by -11.21 %
DVA's Suppliers Net margin fell in Q2 to 5.85 %
Davita Inc's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Davita Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Davita Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
4.89 % 